NeuPath Health Inc.
NPTH.V
TSX
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | -629.30K | -54.20K | -213.20K | -74.80K | -1.14M |
Total Depreciation and Amortization | 1.80M | 1.85M | 1.90M | 1.93M | 1.72M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | 162.10K |
Total Other Non-Cash Items | 752.60K | 124.70K | 58.70K | -18.80K | 998.20K |
Change in Net Operating Assets | 246.30K | -63.90K | 564.70K | 414.10K | 579.40K |
Cash from Operations | 2.17M | 1.85M | 2.31M | 2.25M | 2.31M |
Capital Expenditure | -585.40K | -496.20K | -197.60K | -261.00K | -242.80K |
Sale of Property, Plant, and Equipment | 0.00 | 1.45M | 1.45M | 1.45M | 1.45M |
Cash Acquisitions | -129.80K | -129.80K | -129.80K | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | 0.00 |
Cash from Investing | -715.20K | 822.60K | 1.12M | 1.19M | 1.21M |
Total Debt Issued | 25.00K | 0.00 | 932.00K | 1.05M | 1.00M |
Total Debt Repaid | -2.07M | -3.40M | -3.86M | -4.26M | -4.73M |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 161.00K | 186.00K | 238.00K | 251.00K | 251.00K |
Cash from Financing | -1.39M | -2.38M | -2.00M | -2.20M | -2.58M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 65.90K | 292.00K | 1.43M | 1.24M | 943.70K |